AAAAAA

   
Results: 1-10 |
Results: 10
Risks of elective cardiac surgery: what do patients want to know?
Authors: Beresford, N Seymour, L Vincent, C Moat, N
Citation: N. Beresford et al., Risks of elective cardiac surgery: what do patients want to know?, HEART, 86(6), 2001, pp. 626-631
Delivery by caesarean section - Reply
Authors: Tuffnell, DJ Wilkinson, K Beresford, N
Citation: Dj. Tuffnell et al., Delivery by caesarean section - Reply, BR MED J, 323(7318), 2001, pp. 933-934
Interval between decision and delivery by caesarean section - are current standards achievable? Observational case series
Authors: Tuffnell, DJ Wilkinson, K Beresford, N
Citation: Dj. Tuffnell et al., Interval between decision and delivery by caesarean section - are current standards achievable? Observational case series, BR MED J, 322(7298), 2001, pp. 1330-1333
Estrogenic activity of phenolic additives determined by an in vitro yeast bioassay
Authors: Miller, D Wheals, BB Beresford, N Sumpter, JP
Citation: D. Miller et al., Estrogenic activity of phenolic additives determined by an in vitro yeast bioassay, ENVIR H PER, 109(2), 2001, pp. 133-138
Metabolism and environmental degradation of pyrethroid insecticides produce compounds with endocrine activities
Authors: Tyler, CR Beresford, N van der Woning, M Sumpter, JP Thorpe, K
Citation: Cr. Tyler et al., Metabolism and environmental degradation of pyrethroid insecticides produce compounds with endocrine activities, ENV TOX CH, 19(4), 2000, pp. 801-809
Re-evaluation of the first synthetic estrogen, 1-keto-1,2,3,4-tetrahydrophenanthrene, and bisphenol A, using both the ovariectomised rat model used in 1933 and additional assays
Authors: Ashby, J Odum, J Paton, D Lefevre, PA Beresford, N Sumpter, JP
Citation: J. Ashby et al., Re-evaluation of the first synthetic estrogen, 1-keto-1,2,3,4-tetrahydrophenanthrene, and bisphenol A, using both the ovariectomised rat model used in 1933 and additional assays, TOX LETT, 115(3), 2000, pp. 231-238
Issues arising when interpreting results from an in vitro assay for estrogenic activity
Authors: Beresford, N Routledge, EJ Harris, CA Sumpter, JP
Citation: N. Beresford et al., Issues arising when interpreting results from an in vitro assay for estrogenic activity, TOX APPL PH, 162(1), 2000, pp. 22-33
Obstacles to the prediction of estrogenicity from chemical structure: Assay-mediated metabolic transformation and the apparent promiscuous nature of the estrogen receptor
Authors: Elsby, R Ashby, J Sumpter, JP Brooks, AN Pennie, WD Maggs, JL Lefevre, PA Odum, J Beresford, N Paton, D Park, BK
Citation: R. Elsby et al., Obstacles to the prediction of estrogenicity from chemical structure: Assay-mediated metabolic transformation and the apparent promiscuous nature of the estrogen receptor, BIOCH PHARM, 60(10), 2000, pp. 1519-1530
Partial and weak oestrogenicity of the red wine constituent resveratrol: Consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects
Authors: Ashby, J Tinwell, H Pennie, W Brooks, AN Lefevre, PA Beresford, N Sumpter, JP
Citation: J. Ashby et al., Partial and weak oestrogenicity of the red wine constituent resveratrol: Consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects, J APPL TOX, 19(1), 1999, pp. 39-45
Transformation of a non-oestrogenic steroid metabolite to an oestrogenically active substance by minimal bacterial activity
Authors: Panter, GH Thompson, RS Beresford, N Sumpter, JP
Citation: Gh. Panter et al., Transformation of a non-oestrogenic steroid metabolite to an oestrogenically active substance by minimal bacterial activity, CHEMOSPHERE, 38(15), 1999, pp. 3579-3596
Risultati: 1-10 |